BMAL1 and liver cancer: The survival probability of liver cancer patients with high ARNTL expression was significantly higher than that of liver cancer patients with low ARNTL expression (P = .024), which revealed that low expression of ARNTL indicated poor overall survival of liver cancer patients (Fig. 2C).